InvestorsHub Logo
Followers 1
Posts 147
Boards Moderated 0
Alias Born 03/14/2014

Re: bobbysixty post# 35679

Sunday, 04/10/2016 11:05:48 AM

Sunday, April 10, 2016 11:05:48 AM

Post# of 140474
The premise of Sedasys was right (using pt. feedback loops, pt. controlled hypnotic), but without the blessings of the ASA it was a road to nowhere. Only after awhile did it get limited indications, and unfortunately those were in a field where patients wanted more and more anesthesia (GI), and the indicated patient population was shrinking (ASA I/II undergoing routine (50yo+) colonoscopies...I hear we have an obesity problem in the US).

Albeit, that late, limited ASA blessing was protectionist, I am biased to say that it was rightly prudent. Something like this might work in...Japan or parts of Europe, but the idea of a BMI 38, 50yo ASA II undergoing propofol anesthesia with an anesthesia provider not in the room is a tough pill to swallow.

Yeah. The big companies want to buy proven tech. Proven in the regulatory arena and the possibly the sales arena. However, if they see a proven device that requires a high capital floor to get off the assembly line, I think they can buy before a single sale. SPORT fits this latter category.